Publication:
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

Simple item page
dc.contributor.authorHox, Valerie
dc.contributor.authorLourijsen, Evelijn
dc.contributor.authorJordens, Arnout
dc.contributor.authorAasbjerg, Kristian
dc.contributor.authorAgache, Ioana
dc.contributor.authorAlobid, Isam
dc.contributor.authorBachert, Claus
dc.contributor.authorBoussery, Koen
dc.contributor.authorCampo, Paloma
dc.contributor.authorFokkens, Wytske
dc.contributor.authorHellings, Peter
dc.contributor.authorHopkins, Claire
dc.contributor.authorKlimek, Ludger
dc.contributor.authorMäkelä, Mika
dc.contributor.authorMösges, Ralph
dc.contributor.authorMullol, Joaquim
dc.contributor.authorPujols, Laura
dc.contributor.authorRondon, Carmen
dc.contributor.authorRudenko, Michael
dc.contributor.authorToppila-Salmi, Sanna
dc.contributor.authorScadding, Glenis
dc.contributor.authorScheire, Sophie
dc.contributor.authorTomazic, Peter-Valentin
dc.contributor.authorVan Zele, Thibaut
dc.contributor.authorWagemann, Martin
dc.contributor.authorvan Boven, Job F. M.
dc.contributor.authorGevaert, Philippe
dc.contributor.authoraffiliation[Hox,V] Cliniques Universitaires Saint-Luc Brussels, Brussels, Belgium. [Lourijsen,E; Fokkens,W] Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands. [Jordens,A; Bachert,C; Van Zele,T; Gevaert,P] Upper Airway Research Laboratory, Dep. of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium. [Aasbjerg,K] Bispebjerg University Hospital, Copenhagen, Denmark. [Agache,I] Faculty of Medicine, Transsylvania University, Brasov, Romania. [Alobid,I; Mullol,J; Pujols,L] Hospital Clínic, IDIBAPS, CEBERES Universitat de Barcelona, Catalonia, Spain. [Alobid,I] Centro Medico Teknon, Barcelona, Spain. [Bachert,C] Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden. [Boussery,K; Scheire,S] Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. [Campo,P; Rondon,C] Allergy Unit, Hospital Regional Universitario of Málaga, IBIMA, ARADyAL, Malaga, Spain. [Hellings,P] Department of Ear, Nose and Throat Disease, University Hospitals, Louvain, Belgium. [Hopkins,C] ENT Department, Guy’s & St Thomas’ Hospital, London, UK. [Klimek,L] Center of Rhinology and Allergology, Wiesbaden, Germany. [Mäkelä,M; Toppila‑Salmi,S] Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. [Mösges,R] University of Cologne, Cologne, Germany. [Rudenko,M] London Allergy and Immunology Center, London, UK. [Scadding,G] Royal National Throat, Nose and Ear Hospital, London, UK. [Tomazic,PV] Medical University Graz, Graz, Austria. [Wagemann,M] Heinrich-Heine-University, Düsseldorf, Germany. [van Boven,JFM] Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.
dc.date.accessioned2024-02-12T19:45:08Z
dc.date.available2024-02-12T19:45:08Z
dc.date.issued2020-01-03
dc.description.abstractBecause of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
dc.description.sponsorshipThis work was funded by an EAACI Task Force budget.
dc.identifier.doi10.1186/s13601-019-0303-6
dc.identifier.e-issn2045-7022es_ES
dc.identifier.journalClinical and Translational Allergyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/3699
dc.identifier.pubmedID31908763es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17988
dc.language.isoeng
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://ctajournal.biomedcentral.com/articles/10.1186/s13601-019-0303-6es
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectGlucocorticosteroids
dc.subjectRhinitis
dc.subjectRhinosinusitis
dc.subjectGlucocorticoides
dc.subjectRinitis
dc.subjectSinusitis
dc.subjectPólipos nasales
dc.subjectCorticoesteroides
dc.subject.meshAdrenal Cortex Hormones
dc.subject.meshRhinitis
dc.subject.meshSinusitis
dc.subject.meshNasal Polyps
dc.subject.meshHumans
dc.subject.meshGlucocorticoids
dc.titleBenefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files

Collections

IBIMA-Plataforma BIONAND - Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (Andalucía)
IDIBAPS - Instituto de Investigaciones Biomédicas August Pi i Sunyer (Cataluña)